These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 12074617

  • 1. The effect of steroids on Dupuytren's disease: role of programmed cell death.
    Meek RM, McLellan S, Reilly J, Crossan JF.
    J Hand Surg Br; 2002 Jun; 27(3):270-3. PubMed ID: 12074617
    [Abstract] [Full Text] [Related]

  • 2. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B, Grobbelaar AO, Wilson GD, Smith PJ, Sanders R, McGrouther DA.
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [Abstract] [Full Text] [Related]

  • 3. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA, Wang X, Payne WG, Ko F, Robson MC.
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [Abstract] [Full Text] [Related]

  • 4. Androgen receptors in Dupuytren's contracture.
    Pagnotta A, Specchia N, Greco F.
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [Abstract] [Full Text] [Related]

  • 5. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA, Payne WG, Kierney PC, Pu LL, Smith PD, Siegler K, Ko F, Wang X, Robson MC.
    Int J Surg Investig; 2001 Jan; 2(6):443-56. PubMed ID: 12678125
    [Abstract] [Full Text] [Related]

  • 6. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS, Liu C, Chang EY, Carlson CS, Di Cesare PE.
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [Abstract] [Full Text] [Related]

  • 7. An insight into Dupuytren's contracture.
    Murrell GA.
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [Abstract] [Full Text] [Related]

  • 8. Expression of matrix metalloproteinases and their inhibitors in cords and nodules of patients with Dupuytren's disease.
    Ulrich D, Ulrich F, Piatkowski A, Pallua N.
    Arch Orthop Trauma Surg; 2009 Nov; 129(11):1453-9. PubMed ID: 18758795
    [Abstract] [Full Text] [Related]

  • 9. Langerhans cells in Dupuytren's contracture.
    Qureshi FI, Hornigold R, Spencer JD, Hall SM.
    J Hand Surg Br; 2001 Aug; 26(4):362-7. PubMed ID: 11469841
    [Abstract] [Full Text] [Related]

  • 10. The role of the fibroblast in Dupuytren's contracture.
    Murrell GA.
    Hand Clin; 1991 Nov; 7(4):669-80; discussion 681. PubMed ID: 1769989
    [Abstract] [Full Text] [Related]

  • 11. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J, Rayan GM.
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [Abstract] [Full Text] [Related]

  • 12. Characterization of stem cells in Dupuytren's disease.
    Hindocha S, Iqbal SA, Farhatullah S, Paus R, Bayat A.
    Br J Surg; 2011 Feb; 98(2):308-15. PubMed ID: 21104823
    [Abstract] [Full Text] [Related]

  • 13. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA, Banducci DR, Graham WP, Allison GM, Ehrlich HP.
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [Abstract] [Full Text] [Related]

  • 14. Gelatinase A activity in Dupuytren's disease.
    Augoff K, Ratajczak K, Gosk J, Tabola R, Rutowski R.
    J Hand Surg Am; 2006 Dec; 31(10):1635-9. PubMed ID: 17145384
    [Abstract] [Full Text] [Related]

  • 15. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation.
    Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA.
    Chir Main; 2000 Feb; 19(1):15-22. PubMed ID: 10777424
    [Abstract] [Full Text] [Related]

  • 16. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC, Zhang AY, Chong AK, Pham H, Longaker MT, Chang J.
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [Abstract] [Full Text] [Related]

  • 17. Pharmacologic regulation of Dupuytren's fibroblast contraction in vitro.
    Rayan GM, Parizi M, Tomasek JJ.
    J Hand Surg Am; 1996 Nov; 21(6):1065-70. PubMed ID: 8969433
    [Abstract] [Full Text] [Related]

  • 18. Alterations in the extracellular matrix proteoglycan profile in Dupuytren's contracture affect the palmar fascia.
    Koźma EM, Olczyk K, Wisowski G, Głowacki A, Bobiński R.
    J Biochem; 2005 Apr; 137(4):463-76. PubMed ID: 15858170
    [Abstract] [Full Text] [Related]

  • 19. Epidermal growth factor receptor (EGF-R) in Dupuytren's disease.
    Augoff K, Taboła R, Kula J, Gosk J, Rutowski R.
    J Hand Surg Br; 2005 Dec; 30(6):570-3. PubMed ID: 16055243
    [Abstract] [Full Text] [Related]

  • 20. Dupuytren's disease: comparative growth dynamics and morphology between cultured myofibroblasts (nodule) and fibroblasts (cord).
    Vande Berg JS, Gelberman RH, Rudolph R, Johnson D, Sicurello P.
    J Orthop Res; 1984 Dec; 2(3):247-56. PubMed ID: 6491814
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.